Literature DB >> 21164073

Final report of the safety assessment of Kojic acid as used in cosmetics.

Christina L Burnett1, Wilma F Bergfeld, Donald V Belsito, Ronald A Hill, Curtis D Klaassen, Daniel C Liebler, James G Marks, Ronald C Shank, Thomas J Slaga, Paul W Snyder, F Alan Andersen.   

Abstract

Kojic acid functions as an antioxidant in cosmetic products. Kojic acid was not a toxicant in acute, chronic, reproductive, and genotoxicity studies. While some animal data suggested tumor promotion and weak carcinogenicity, kojic acid is slowly absorbed into the circulation from human skin and likely would not reach the threshold at which these effects were seen. The available human sensitization data supported the safety of kojic acid at a use concentration of 2% in leave-on cosmetics. Kojic acid depigmented black guinea pig skin at a concentration of 4%, but this effect was not seen at 1%. The Cosmetic Ingredient Review (CIR) Expert Panel concluded that the 2 end points of concern, dermal sensitization and skin lightening, would not be seen at use concentrations below 1%; therefore, this ingredient is safe for use in cosmetic products up to that level.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164073     DOI: 10.1177/1091581810385956

Source DB:  PubMed          Journal:  Int J Toxicol        ISSN: 1091-5818            Impact factor:   2.032


  16 in total

1.  Wound healing by topical application of antioxidant iron chelators: kojic acid and deferiprone.

Authors:  Mehrdad Mohammadpour; Mohaddeseh Behjati; Amir Sadeghi; Afshin Fassihi
Journal:  Int Wound J       Date:  2012-05-24       Impact factor: 3.315

2.  Comparative Study on Depigmenting Agents in Skin of Color.

Authors:  Achala Liyanage; Gayani Liyanage; Ganga Sirimanna; Nanna Schürer
Journal:  J Clin Aesthet Dermatol       Date:  2022-02

Review 3.  Skin Changes and Safety Profile of Topical Products During Pregnancy.

Authors:  Imam Budi Putra; Nelva Karmila Jusuf; Nani Kumala Dewi
Journal:  J Clin Aesthet Dermatol       Date:  2022-02

4.  Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris.

Authors:  Tarnyamas Kaewsanit; Panlop Chakkavittumrong; Neti Waranuch
Journal:  J Clin Aesthet Dermatol       Date:  2021-06-01

5.  Ecdysteroid kinase-like (EcKL) paralogs confer developmental tolerance to caffeine in Drosophila melanogaster.

Authors:  Jack L Scanlan; Paul Battlay; Charles Robin
Journal:  Curr Res Insect Sci       Date:  2022-01-16

6.  Preventive Therapy of Experimental Colitis with Selected iron Chelators and Anti-oxidants.

Authors:  Mohsen Minaiyan; Elahe Mostaghel; Parvin Mahzouni
Journal:  Int J Prev Med       Date:  2012-03

7.  Sequential release of salidroside and paeonol from a nanosphere-hydrogel system inhibits ultraviolet B-induced melanogenesis in guinea pig skin.

Authors:  Li-Hua Peng; Shen-Yao Xu; Ying-Hui Shan; Wei Wei; Shuai Liu; Chen-Zhen Zhang; Jia-He Wu; Wen-Quan Liang; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2014-04-16

8.  The unravelling of the complex pattern of tyrosinase inhibition.

Authors:  Batel Deri; Margarita Kanteev; Mor Goldfeder; Daniel Lecina; Victor Guallar; Noam Adir; Ayelet Fishman
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

9.  Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Umesh Chaudhari; Harshal Nemade; Poornima Sureshkumar; Mathieu Vinken; Gamze Ates; Vera Rogiers; Jürgen Hescheler; Jan Georg Hengstler; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2017-09-22       Impact factor: 5.153

10.  Synthesis and biological evaluation of unsymmetrical curcumin analogues as tyrosinase inhibitors.

Authors:  Yongfu Jiang; Zhiyun Du; Guihua Xue; Qian Chen; Yujing Lu; Xi Zheng; Allan H Conney; Kun Zhang
Journal:  Molecules       Date:  2013-04-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.